Abonnieren

Anmelden

3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success Story - B&C-Gruppe

3rd Prize Public Choice: SARS-CoV-2 Antibody Tests: An Austrian Success  Story - B&C-Gruppe

Institution: University of Natural Resources and Life Sciences, Vienna (BOKU), Department of Biotechnology Project lead: DI Miriam Klausberger, Ph.D., DI Mark Dürkop, Ph.D. Project description (German): Ein SARS-CoV-2-Antikörpertest gibt Auskunft darüber, ob jemand bereits mit dem Coronavirus infiziert war oder ob im Rahmen einer Impfung Antikörper gebildet wurden. Für den Antikörpernachweis nach einer Infektion oder […]

Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2

2021 Houska Prize Review - B&C Gruppe

Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2: Molecular Therapy

Assessing the impact of SARS-CoV-2 prevention measures in Austrian schools using agent-based simulations and cluster tracing data

High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl

COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications - IOS Press

Federal Register :: COVID-19 Vaccination and Testing; Emergency Temporary Standard

Assessing the impact of SARS-CoV-2 prevention measures in Austrian schools by means of agent-based simulations calibrated to cluster tracing data

HIV Glasgow, 23–26 October 2022, Glasgow, UK / Virtual - 2022 - Journal of the International AIDS Society - Wiley Online Library

HIV Glasgow, 23–26 October 2022, Glasgow, UK / Virtual - 2022 - Journal of the International AIDS Society - Wiley Online Library